The U.S. Department of Transportation published a final rule April 23 that makes technical corrections to regulations governing drug testing for safety-sensitive employees to ensure consistency with recent amendments made to DOT’s “Procedures for Transportation Workplace Drug and Alcohol Testing Programs,” which recently added requirements for testing for oxycodone, oxymorphone, hydrocodone and hydromorphone.
According to the release from DOT, the new changes to the department’s regulations make it necessary to refer to these substances, as well as morphine, 6-acetylmorphine and codeine by the term “opioids” rather than “opiates.”
This final rule amends the term in the FAA, FTA and PHMSA regulations to ensure that all DOT drug testing rules are consistent with one another and the mandatory guidelines for the testing program.
Click here to read more about this final rule.
Related News
- Semi Crushes Member in Decatur, Ill.
- Long-time Union Ally Mikie Sherrill Runs for New Jersey Governor
- FRA Suspends Safety Reports due to Government Shutdown
- SMART-TD to Port Terminal Railroad Association: Your Harassment Stops Now.
- Honoring the Professional Drivers Who Keep Our Children Safe
- Report Transit Assaults to Help SMART-TD Fight Back
- Another RRB Office Moves to New Location
- Hunting accident claims life of Idaho member’s daughter
- Gardena City Council welcomes SMART-TD to represent GTrans Bus Operators
- NO On-Site Registration Available at Atlanta Regional Training Seminar